Sino Biopharmaceutical (OTCMKTS:SBMFF) Shares Up 0.8% – What’s Next?

Shares of Sino Biopharmaceutical (OTCMKTS:SBMFF) were up 0.8% during mid-day trading on Wednesday . The stock traded as high as $0.8721 and last traded at $0.8721. Approximately 202 shares were traded during trading, a decline of 92% from the average daily volume of 2,460 shares. The stock had previously closed at $0.8654.

Sino Biopharmaceutical Price Performance

The stock has a 50-day moving average price of $0.94 and a 200 day moving average price of $0.85.

Sino Biopharmaceutical Company Profile

Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines, including anlotinib hydrochloride capsules under Focus V brand, penpulimab injection under Annike brand, efbemalenograstin alfa injection under Yilishu brand, pomalidomide capsules under Anyue brand, bevacizumab injection under Anbeisi brand, rituximab injection under Delituo brand, and trastuzumab for injection under Saituo brand; liver disease medications, such as magnesium isoglycyrrhizinate injection under Tianqing Ganmei brand and entecavir dispersible tablets under Runzhong brand; and respiratory system medicines comprising budesonide suspension for inhalation under Tianqing suchang brand and colistimethate sodium for injection under Tianyun brand.